First-in-human trial in Burkinabe adults and children of replication-competent, genetically attenuated PfSPZ-LARC2 Vaccine for malaria
- DOI
- 10.64898/2026.10.16.26365330
- Published
- 2026-10-21
- Container
- Not recorded
- Publisher
- openRxiv
- Open access
- unknown
Credibility signals
uncertain Score 60/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- cautionPublication version: Identified as a preprint; peer review and later versions may change the record.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.64898/2026.10.16.26365330,
title = {First-in-human trial in Burkinabe adults and children of replication-competent, genetically attenuated PfSPZ-LARC2 Vaccine for malaria},
author = {Sodiomon B. Sirima and Thomas L Richie and Alphonse Ouedraogo and Ben I. Soulama and Aminata R. Zou and Issa Nebié and KC Natasha and Nelly Camargo and Debashree Goswami and Jean Moïse T. Kabore and Nafissatou Kirakoya and Rolel K. Mbaiasra and Sem Ezinmegnon and Emilie S. Badoum and Sinndia Y. Ouedraogo and Noelie B. Henry and Jean B. Yaro and Thabo Mabuka and Tooba Murshedkar and Yonas Abebe and Diana Perez and Eric R. James and Nana Minkah and Ashley M. Vaughan and Matthew B. Laurens and B. Kim Lee Sim and Stefan H. I. Kappe and Alfred B. Tiono and Stephen L. Hoffman},
year = {2026},
doi = {10.64898/2026.10.16.26365330},
url = {https://doi.org/10.64898/2026.10.16.26365330}
}RIS
TY - JOUR TI - First-in-human trial in Burkinabe adults and children of replication-competent, genetically attenuated PfSPZ-LARC2 Vaccine for malaria AU - Sodiomon B. Sirima AU - Thomas L Richie AU - Alphonse Ouedraogo AU - Ben I. Soulama AU - Aminata R. Zou AU - Issa Nebié AU - KC Natasha AU - Nelly Camargo AU - Debashree Goswami AU - Jean Moïse T. Kabore AU - Nafissatou Kirakoya AU - Rolel K. Mbaiasra AU - Sem Ezinmegnon AU - Emilie S. Badoum AU - Sinndia Y. Ouedraogo AU - Noelie B. Henry AU - Jean B. Yaro AU - Thabo Mabuka AU - Tooba Murshedkar AU - Yonas Abebe AU - Diana Perez AU - Eric R. James AU - Nana Minkah AU - Ashley M. Vaughan AU - Matthew B. Laurens AU - B. Kim Lee Sim AU - Stefan H. I. Kappe AU - Alfred B. Tiono AU - Stephen L. Hoffman PY - 2026 DO - 10.64898/2026.10.16.26365330 UR - https://doi.org/10.64898/2026.10.16.26365330 ER -
APA
Sirima, S. B., Richie, T. L., Ouedraogo, A., Soulama, B. I., Zou, A. R., Nebié, I., Natasha, K., Camargo, N., Goswami, D., Kabore, J. M. T., Kirakoya, N., Mbaiasra, R. K., Ezinmegnon, S., Badoum, E. S., Ouedraogo, S. Y., Henry, N. B., Yaro, J. B., Mabuka, T., Murshedkar, T., Abebe, Y., Perez, D., James, E. R., Minkah, N., Vaughan, A. M., Laurens, M. B., Sim, B. K. L., Kappe, S. H. I., Tiono, A. B., & Hoffman, S. L. (2026). First-in-human trial in Burkinabe adults and children of replication-competent, genetically attenuated PfSPZ-LARC2 Vaccine for malaria. https://doi.org/10.64898/2026.10.16.26365330
Source records
- crossref · retrieved 2026-11-10T11:59:19.144Z